News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|August 2, 2015

Being Diagnosed With Cancer

Episodes in this series

EP. 1 Being Diagnosed With Cancer

EP. 1 Being Diagnosed With Cancer

EP. 2 Talking to Your Doctor About Your Diagnosis

EP. 2 Talking to Your Doctor About Your Diagnosis

EP. 3 Learning About Your Prognosis

EP. 3 Learning About Your Prognosis

EP. 4 Cancer and Family Matters

EP. 4 Cancer and Family Matters

EP. 5 Myths About Cancer and Treatment

EP. 5 Myths About Cancer and Treatment

EP. 6 Logistics, Appointments, and Clinical Trials

EP. 6 Logistics, Appointments, and Clinical Trials

Newsletter

Stay up to date on cancer updates, research and education

Related Content

follicular lymphoms

Yescarta Shows Durable Responses and Manageable Safety in Real-World R/R FL

December 9th 2025

Dexamethasone before Yescarta reduced the severity of ICANS but did not change how often ICANS or CRS occurred in patients with LBCL.

Dexamethasone May Ease Severe Neurotoxicity With Yescarta in LBCL

December 9th 2025

Pelabresib plus Jakafi delivered stronger, clinically meaningful benefits versus Jakafi alone for people with untreated myelofibrosis.

New Data Support Pelabresib Combination in Untreated Myelofibrosis

December 9th 2025

$Tecvayli plus Darzalex Faspro improved overall and progression-free survival versus standard daratumumab regimens in relapsed/refractory multiple myeloma.$

Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma

ByJason Broderick

December 9th 2025

Jaypirca therapy improved progression-free survival versus bendamustine plus Rituxan a phase 3 trial for untreated CLL/SLL: © stock.adobe.com.

Jaypirca Significantly Improves PFS Outcomes in Untreated CLL/SLL

BySabrina Serani

December 9th 2025

Trending on CURE

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

Epkinly Plus Chemo Elicits Durable Responses in DLBCL

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

Insights Into What’s New in Blood Cancer Care

Breaking Down the Prostate Cancer Treatment Renaissance

© 2025 MJH Life Sciences^®

All rights reserved.